Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat

Damien Roux1, Stéphane Gaudry, Didier Dreyfuss

  • 1INSERM U 722 and Université Paris 7-Denis Diderot, UFR de Médecine site Xavier Bichat, Paris.

Critical Care Medicine
|February 25, 2009
PubMed
Abstract

Insights

Candida albicans airway colonization increases the risk of Pseudomonas aeruginosa pneumonia in rats by reducing macrophage defenses. Antifungal therapy may help prevent bacterial pneumonia, especially in vulnerable patients.

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonology

Background:

  • Fungal colonization of the airways can predispose to bacterial infections.
  • The interaction between Candida albicans and Pseudomonas aeruginosa in the lung is not fully understood.

Purpose of the Study:

  • To investigate if Candida albicans airway colonization affects the prevalence of Pseudomonas aeruginosa pneumonia in a rat model.
  • To elucidate the underlying mechanisms of this interaction.

Main Methods:

  • A prospective, randomized, controlled animal study was conducted using male Wistar rats.
  • Pneumonia was induced by bronchial instillation of P. aeruginosa in rats pre-exposed to live or killed C. albicans.
  • Lung cytokine levels and alveolar macrophage reactive oxygen species (ROS) production were measured.

Main Results:

  • P. aeruginosa pneumonia prevalence was significantly higher in rats colonized with live C. albicans compared to controls.
  • Live C. albicans colonization increased pro-inflammatory cytokines (TNF-α, IFN-γ) but decreased ROS production by macrophages.
  • Ethanol-killed C. albicans did not influence P. aeruginosa pneumonia prevalence or macrophage function.

Conclusions:

  • Candida albicans airway colonization impairs alveolar macrophage ROS production, increasing susceptibility to P. aeruginosa pneumonia.
  • This study highlights the critical role of fungal colonization in modulating bacterial lung infections.
  • Findings suggest potential benefits of antifungal therapy in preventing P. aeruginosa-associated pneumonia, particularly ventilator-associated pneumonia.

Related Concept Videos